Ad
Monday, 12 June 2017
Chi-Med steps closer to Chinese pharma first with drug filing
LONDON (Reuters) - Hutchison China MediTech, the Shanghai-based drugmaker listed in London, is a step closer to winning approval for a modern drug developed in a Chinese lab with the submission of its cancer medicine fruquintinib to China's drug watchdog.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment